Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05890274 · ClinicalTrials.gov registry record · NA

Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO

A NA study of Atrial Fibrillation, sponsored by University of North Carolina, Chapel Hill.

Active
Registry status
NA
Development phase
120
Enrollment target
3
Study locations

NCT05890274 is a NA study of Atrial Fibrillation that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 120 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05890274, a NA study of Atrial Fibrillation, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
3
Study locations

Study Summary

The goal of this study is to determine the effectiveness of a direct-to-provider virtual education program ("AF and EKG Interpretation Project ECHO") for primary care providers who manage patients with atrial fibrillation (AF). The main questions this study aims to answer are: 1. Will participants have improvement in knowledge and confidence in managing patients with atrial fibrillation after program completion? 2. Will quality and performance metrics improve at the patient level for program participants? Participants will be asked to: * Participate in 12 hours of virtual education sessions over twelve weeks via Zoom. * Complete a knowledge and confidence assessment online before the program starts and after its completion.

Conditions Studied

Atrial Fibrillation

Interventions

  • OTHER AF and EKG Interpretation Project ECHO

Study Locations (3)

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill
  • Duke University - Durham
  • Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-09-04
Est. Completion 2026-02
Phase NA

Sponsor

University of North Carolina, Chapel Hill

1,109 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05890274

The ClinicalTrials.gov registry entry for NCT05890274 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which AF and EKG Interpretation Project ECHO is the first listed.

NCT05890274 reports 3 study locations spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05890274 about?

NCT05890274 is a clinical study titled "Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO". The goal of this study is to determine the effectiveness of a direct-to-provider virtual education program ("AF and EKG Interpretation Project ECHO") for primary care providers who manage patients with atrial fibrillation (AF). The main questions this study aims to answer are: 1. Will participants ...

What is the current status of trial NCT05890274?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-09-04. Estimated completion is 2026-02.

What conditions does trial NCT05890274 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT05890274?

The interventions under investigation include: AF and EKG Interpretation Project ECHO (OTHER).

Who is sponsoring clinical trial NCT05890274?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05890274 being conducted?

This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.